NCDB cancer bytes
Neoadjuvant and perioperative chemotherapy for localized pancreatic cancer: Leveraging small and large databases in the absence of Level 1 evidence(0)
In the rapidly evolving clinical paradigms for localized pancreatic cancer, a combination of Level 1 data and large and small database studies can inform disease management.
The potential role of NCDB data in treating rare malignancy is explored.
This article compares demographic data of astrocytomas and glioblastomas patients documented in the NCDB, a hospital-based cancer registry, with cases in the Central Brain Tumor Registry of the U.S.
Both retrospective and prospective data are assessed to determine the quality of life outcomes for patients undergoing brachytherapy to treat prostate cancer.
To determine the impact of age on thyroid cancer mortality, researchers investigated trends in outcomes from these cases in the National Cancer Database.
More in this category
- Active surveillance as a treatment modality in ductal carcinoma in situ
- Endometrial cancer: An increasingly common gynecologic malignancy
- Using data to plan cancer prevention and screening activities
- Strategically reversing the rising incidence of melanoma in younger patients
- The impact of financial barriers on access to quality care in breast cancer
- Using the NCDB to explore trends in cancer